356 related articles for article (PubMed ID: 12429067)
41. Activity-dependent isolation of the presenilin- gamma -secretase complex reveals nicastrin and a gamma substrate.
Esler WP; Kimberly WT; Ostaszewski BL; Ye W; Diehl TS; Selkoe DJ; Wolfe MS
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2720-5. PubMed ID: 11867728
[TBL] [Abstract][Full Text] [Related]
42. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1.
Li YM; Xu M; Lai MT; Huang Q; Castro JL; DiMuzio-Mower J; Harrison T; Lellis C; Nadin A; Neduvelil JG; Register RB; Sardana MK; Shearman MS; Smith AL; Shi XP; Yin KC; Shafer JA; Gardell SJ
Nature; 2000 Jun; 405(6787):689-94. PubMed ID: 10864326
[TBL] [Abstract][Full Text] [Related]
43. C-terminal PAL motif of presenilin and presenilin homologues required for normal active site conformation.
Wang J; Beher D; Nyborg AC; Shearman MS; Golde TE; Goate A
J Neurochem; 2006 Jan; 96(1):218-27. PubMed ID: 16305624
[TBL] [Abstract][Full Text] [Related]
44. Two domains within the first putative transmembrane domain of presenilin 1 differentially influence presenilinase and gamma-secretase activity.
Brunkan AL; Martinez M; Wang J; Walker ES; Beher D; Shearman MS; Goate AM
J Neurochem; 2005 Sep; 94(5):1315-28. PubMed ID: 16001967
[TBL] [Abstract][Full Text] [Related]
45. [Presenilins in the genesis of Alzheimer s disease].
Pérez-Tur J
Rev Neurol; 2001 Nov 16-30; 33(10):967-72. PubMed ID: 11785012
[TBL] [Abstract][Full Text] [Related]
46. Presenilin function and gamma-secretase activity.
Brunkan AL; Goate AM
J Neurochem; 2005 May; 93(4):769-92. PubMed ID: 15857382
[TBL] [Abstract][Full Text] [Related]
47. The presenilins and Alzheimer's disease.
Hutton M; Hardy J
Hum Mol Genet; 1997; 6(10):1639-46. PubMed ID: 9300655
[TBL] [Abstract][Full Text] [Related]
48. Presenilin and gamma-secretase: structure meets function.
Wolfe MS
J Neurochem; 2001 Mar; 76(6):1615-20. PubMed ID: 11259478
[No Abstract] [Full Text] [Related]
49. In vitro characterization of the presenilin-dependent gamma-secretase complex using a novel affinity ligand.
Beher D; Fricker M; Nadin A; Clarke EE; Wrigley JD; Li YM; Culvenor JG; Masters CL; Harrison T; Shearman MS
Biochemistry; 2003 Jul; 42(27):8133-42. PubMed ID: 12846562
[TBL] [Abstract][Full Text] [Related]
50. Amyloid, presenilins, and Alzheimer's disease.
Van Gassen G; Annaert W
Neuroscientist; 2003 Apr; 9(2):117-26. PubMed ID: 12708616
[TBL] [Abstract][Full Text] [Related]
51. FAD mutations in presenilin-1 or amyloid precursor protein decrease the efficacy of a gamma-secretase inhibitor: evidence for direct involvement of PS1 in the gamma-secretase cleavage complex.
Xia W; Ostaszewski BL; Kimberly WT; Rahmati T; Moore CL; Wolfe MS; Selkoe DJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):673-81. PubMed ID: 11114265
[TBL] [Abstract][Full Text] [Related]
52. Protease digestion indicates that endogenous presenilin 1 is present in at least two physical forms.
Oh YS; Turner RJ
Biochem Biophys Res Commun; 2006 Jul; 346(1):330-4. PubMed ID: 16756946
[TBL] [Abstract][Full Text] [Related]
53. Alzheimer's disease. Molecular consequences of presenilin-1 mutation.
Gandy S; Naslund J; Nordstedt C
Nature; 2001 Jun; 411(6838):654-6. PubMed ID: 11395757
[TBL] [Abstract][Full Text] [Related]
54. Functional reconstitution of gamma-secretase through coordinated expression of presenilin, nicastrin, Aph-1, and Pen-2.
Periz G; Fortini ME
J Neurosci Res; 2004 Aug; 77(3):309-22. PubMed ID: 15248287
[TBL] [Abstract][Full Text] [Related]
55. Length and overall sequence of the PEN-2 C-terminal domain determines its function in the stabilization of presenilin fragments.
Prokop S; Haass C; Steiner H
J Neurochem; 2005 Jul; 94(1):57-62. PubMed ID: 15953349
[TBL] [Abstract][Full Text] [Related]
56. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
57. Caveolin-3 upregulation activates beta-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease.
Nishiyama K; Trapp BD; Ikezu T; Ransohoff RM; Tomita T; Iwatsubo T; Kanazawa I; Hsiao KK; Lisanti MP; Okamoto T
J Neurosci; 1999 Aug; 19(15):6538-48. PubMed ID: 10414982
[TBL] [Abstract][Full Text] [Related]
58. Abeta-generating enzymes: recent advances in beta- and gamma-secretase research.
Vassar R; Citron M
Neuron; 2000 Sep; 27(3):419-22. PubMed ID: 11055423
[No Abstract] [Full Text] [Related]
59. Presenilin-1 mutations in Alzheimer's disease.
Russo C; Schettini G; Saido TC; Hulette C; Lippa C; Lannfelt L; Ghetti B; Gambetti P; Tabaton M; Teller JK
Nature; 2000 Jun; 405(6786):531-2. PubMed ID: 10850703
[No Abstract] [Full Text] [Related]
60. Endoproteolysis of the ER stress transducer ATF6 in the presence of functionally inactive presenilins.
Steiner H; Winkler E; Shearman MS; Prywes R; Haass C
Neurobiol Dis; 2001 Aug; 8(4):717-22. PubMed ID: 11493036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
